CAS 459168-97-9

MJN228

CAS : 459168-97-9

MJN228

Degré de pureté : ≥98%

Masse moléculaire : 364.4g/mol

Ref: 54-BUP00677

MJN228

CAS : 459168-97-9

MJN228 is an experimental drug that binds to a specific site on the protein. It is being developed as a potential treatment for obesity, diabetes, and other metabolic diseases. MJN228 has been shown to bind to lipids, which are fatty molecules that are important in metabolism. Binding of MJN228 to these lipids may alter the way they interact with proteins.

Formule : C₂₀H₂₀N₄O₃

Degré de pureté : Min. 95%

Masse moléculaire : 364.4 g/mol

Ref: 3D-JTA16897

MJN228

CAS : 459168-97-9

MJN228 is a NUCB1 inhibitor that blocks AEA-DA probe labeling of endogenous NUCB1 in Neuro2a cells and can be used to study metabolic disorders.

Formule : C₂₀H₂₀N₄O₃

Degré de pureté : 98.42%

Couleur et forme : Solid

Masse moléculaire : 364.4

Ref: TM-T28050